On 17 May 2026, the World Health Organization (WHO) declared the Ebola virus disease outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo (DRC) and Uganda a Public Health Emergency of International Concern.
An agency of the European Union
Frequent searches:
On 17 May 2026, the World Health Organization (WHO) declared the Ebola virus disease outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo (DRC) and Uganda a Public Health Emergency of International Concern.
Guidance, training materials and operational resources for public health authorities, healthcare professionals and transport operators.
Communication materials and resources for the public, healthcare professionals, airlines and airport staff.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 June, and includes updates on measles, Nipah virus infection, Chikungunya virus disease, Hantavirus, Ebola, and West Nile virus.
Communicable disease threats report, 6 - 12 June 2026, Week 24.pdf
English (2.36 MB - PDF)
This list below shows the current accommodation sites in EU/EEA countries with which clusters of Legionnaires’ disease have been identified but where the European Legionnaires’ disease Surveillance Network (ELDSNet) is unable to assess the risk of Legionella infection, or where ELDSNet believe there may be increased risk to travellers.
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
Weekly update with the latest reports on West Nile virus cases in Europe.
Healthcare professionals play a critical role in the early identification and safe management of suspected Ebola disease cases. Imported cases in Europe are expected to be very rare.
The overall risk of Bundibugyo virus transmission through substances of human origin (SoHO) in the European Union/European Economic Area (EU/EEA) is currently assessed as very low.
Risk of Bundibugyo virus transmission through substances of human origin in the European Union/European Economic Area (EU/EEA)
English (250.38 KB - PDF)
On 4 June 2026, the European Union Reference Laboratory for Public Health on AMR (EURL-PH-AMR) published the ‘Summary report on EARS-Net EQA 2025’. It describes the results of the 2025 external quality assessment (EQA) exercise for antimicrobial susceptibility testing (AST) by clinical laboratories that participate in the European Antimicrobial Resistance Surveillance Network (EARS-Net).
Healthcare professionals play a critical role in the early identification and safe management of suspected Ebola disease cases. Imported cases in Europe are expected to be very rare.
This Reporting Protocol describes data collection for influenza, COVID-19, and other respiratory viruses (such as RSV or new viruses of public health concern) in the EU/EEA and wider WHO European Region. Data collection is integrated for most datasets in line with the operational considerations for respiratory virus surveillance in Europe.
EpiPulse Cases - Reporting Protocol for integrated respiratory virus surveillance, version 1.2
English (1.64 MB - PDF)The Management Board approves and monitors the implementation of ECDC’s work programme and budget, it adopts its annual report and accounts - all in all, it acts as the governing body of the Centre.
Since April 2012, and as of 1 June 2026, a total of 2 649 MERS cases, including 960 deaths, have been reported by health authorities worldwide.
Since April 2012, and as of 1 June 2026, a total of 2 649 MERS cases, including 960 deaths, have been reported by health authorities worldwide.
Since April 2012, and as of 1 June 2026, a total of 2 649 MERS cases, including 960 deaths, have been reported by health authorities worldwide.
Since April 2012, and as of 1 June 2026, a total of 2 649 MERS cases, including 960 deaths, have been reported by health authorities worldwide.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 May 2026, and includes updates on SARS-CoV-2 variant classification, Ebola, Middle East respiratory syndrome (MERS), mpox, West Nile virus, Salmonella, Dermatophilus congolensis and malaria.
Communicable disease threats report, 30 May - 5 June 2026, Week 23
English (5.26 MB - PDF)Minutes of the 84th meeting of the ECDC Advisory Forum, 17-18 February 2026.
Minutes of the 84th meeting of the ECDC Advisory Forum, Stockholm, 17-18 February 2026.pdf
English (272.08 KB - PDF)
Preliminary findings from the first cycle of Public Health Emergency Preparedness Assessments – Interim report
Preliminary findings from the first cycle of Public Health Emergency Preparedness Assessments – Interim report.pdf
English (3.73 MB - PDF)
Answers to common questions including information on the risk to Europe, hantavirus and Andesvirus, and what ECDC is doing to help control the outbreak.
This leaflet provides guidance on what to do for contact tracing for health authorities.
This leaflet explains what to do if a passenger develops symptoms of Ebola disease.
Questions and answers about the current outbreak of Ebola disease for healthcare professionals in Europe.
Maps of surveillance activities and current known distributions of sandfly species in Europe and neighbouring regions.